Kaposiform Hemangioendothelioma Clinical Trials in Chengdu, Sichuan
2 recruitingChengdu, Sichuan, China
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP
Kaposiform Hemangioendothelioma (KHE)Kasabach Merritt Phenomenon
Yi Ji76 enrolled1 locationNCT07656909
Recruiting
Phase 2
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
West China Hospital50 enrolled1 locationNCT04056962